Global Cord Blood Corp
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation… Read more
Global Cord Blood Corp (CORBF) - Total Liabilities
Latest total liabilities as of June 2022: $575.70 Million USD
Based on the latest financial reports, Global Cord Blood Corp (CORBF) has total liabilities worth $575.70 Million USD as of June 2022.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Global Cord Blood Corp - Total Liabilities Trend (2007–2022)
This chart illustrates how Global Cord Blood Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Global Cord Blood Corp Competitors by Total Liabilities
The table below lists competitors of Global Cord Blood Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Saha Pathanapibul Public Company Limited
BK:SPC
|
Thailand | ฿9.88 Billion |
|
Kitex Garments Limited
NSE:KITEX
|
India | ₹15.29 Billion |
|
ECB Bancorp Inc.
NASDAQ:ECBK
|
USA | $1.43 Billion |
|
Stellar V Capital Corp. Unit
NASDAQ:SVCCU
|
USA | $5.37 Million |
|
Hubtown Limited
NSE:HUBTOWN
|
India | ₹31.54 Billion |
|
Guangxi Guidong Eletric Power Co Ltd
SHG:600310
|
China | CN¥18.01 Billion |
|
Far East Orchard Ltd
F:O5P
|
Germany | €1.28 Billion |
|
Hangzhou Huasu Technology Co. Ltd. A
SHE:301157
|
China | CN¥136.96 Million |
Liability Composition Analysis (2007–2022)
This chart breaks down Global Cord Blood Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 10.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Global Cord Blood Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Global Cord Blood Corp (2007–2022)
The table below shows the annual total liabilities of Global Cord Blood Corp from 2007 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-03-31 | $3.65 Billion | +3.74% |
| 2021-03-31 | $3.52 Billion | +5.60% |
| 2020-03-31 | $3.33 Billion | +6.49% |
| 2019-03-31 | $3.13 Billion | +14.77% |
| 2018-03-31 | $2.73 Billion | -18.40% |
| 2017-03-31 | $3.34 Billion | +12.30% |
| 2016-03-31 | $2.97 Billion | +15.46% |
| 2015-03-31 | $2.58 Billion | +17.58% |
| 2014-03-31 | $2.19 Billion | +25.57% |
| 2013-03-31 | $1.74 Billion | +196.47% |
| 2012-03-31 | $588.52 Million | +25.16% |
| 2011-03-31 | $470.21 Million | +106.75% |
| 2010-03-31 | $227.43 Million | +301.04% |
| 2009-03-31 | $56.71 Million | +8.52% |
| 2008-03-31 | $52.26 Million | -5.52% |
| 2007-03-31 | $55.31 Million | -- |